DANE SHOEMAKER: Open Payments
NPI 1568713675 · PETALUMA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,556 in 98 payments from 15 companies in 2025. Trend: 2023 $2,496 · 2024 $2,282 · 2025 $2,556
Food & beverage: $2,467Education: $89
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $585 |
| Janssen Biotech, Inc. | 15 | $434 |
| Lilly USA, LLC | 12 | $398 |
| Gilead Sciences, Inc. | 13 | $288 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $285 |
| Aimmune Therapeutics, Inc. | 5 | $133 |
| Madrigal Pharmaceuticals | 5 | $118 |
| Intercept Pharmaceuticals, Inc. | 4 | $81 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $50 |
| PFIZER INC. | 2 | $47 |
Products named: TREMFYA, RINVOQ, OMVOH, ENTYVIO, ZENPEP, REZDIFFRA, CREON, SKYRIZI.
Industry payments across CA — which companies pay providers there.
